- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05988060
Physical Exercise for Patients With Head and Neck Cancer (VITAL)
The Effect of Physical Exercise During Radiotherapy on Physical Functioning in Patients With Head and Neck Cancer: a Trial Within Cohorts, the VITAL Study
The goal of this trial within cohorts study is to determine and compare physical performance, muscle strength, fatigue, quality of life, body composition, nutritional status, physical activity, treatment tolerability of radiotherapy (RT), chemoradiation (CRT) or bioradiation (BRT), and healthcare related costs in patients with head and neck cancer (HNC) with and without a 10 week physical exercise intervention (PEI) during RT, CRT or BRT ((C/B)RT).
Patients who were randomized in the PEI group and accepted the invitation to undergo the experimental intervention receive a PEI twice a week for 10 weeks. The PEI will be executed 6 to 7 weeks during and 3 to 4 weeks after (C/B)RT.
Researchers will compare patients who undergo the PEI with patients who did not undergo the PEI to see if there is difference in physical performance, muscle strength, fatigue, Quality of Life, body composition, nutritional status, physical activity, treatment tolerability of (C/B)RT , and healthcare related costs in patients with Head and Neck Cancer (HNC) with and without a 10 week Physical Exercise Intervention (PEI) during (C/B)RT).
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Caroline Speksnijder, Dr.
- Phone Number: +3188758040
- Email: C.M.Speksnijder@umcutrecht.nl
Study Contact Backup
- Name: Jorine Vermaire, Dr.
- Phone Number: +135947777
- Email: vermaire.j@bvi.nl
Study Locations
-
-
Noord Brabant
-
Tilburg, Noord Brabant, Netherlands, 5042 SB
- Recruiting
- Instituut Verbeeten
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- patients with HNC who are scheduled for (C/B)RT,
- ≥18 years of age,
- sufficient Dutch writing and reading skills,
- a Karnofsky performance status (KPS) >60,
- able to walk ≥60m without a mobility aid, and
- no contraindication for physical activity as measured with the physical activity readiness questionnaire (PAR-Q).
Exclusion Criteria:
- recurrence of HNC and/or
- secondary HNC.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Patients who were randomized in the PEI group and accepted the invitation
The experimental intervention consist of a PEI for 10 weeks.
The PEI will be executed 6 to 7 weeks during and 3 to 4 weeks after (C/B)RT.
|
Patients who were randomized in the PEI group and accepted the invitation to undergo the experimental intervention receive a PEI for 10 weeks. The PEI will be executed 6 to 7 weeks during and 3 to 4 weeks after (C/B)RT. The PEI consists of a 60 minutes intervention twice a week and will be supervised by a physiotherapist specialized in oncology. Patients who receive the intervention also have to do home-based aerobic and muscle strength exercises by themselves three times a week.
Other Names:
|
No Intervention: Patients who were not randomized in the PEI group
Patients will receive usual care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
physical performance
Time Frame: M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)
|
six minute walking test
|
M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Muscle strength
Time Frame: M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)
|
Grip strength
|
M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)
|
Muscle strength
Time Frame: M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)
|
30 seconds chair to stand test
|
M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)
|
Muscle strength
Time Frame: M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)
|
Microfet handheld dynamometer
|
M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)
|
Health Related Quality of Life
Time Frame: M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)
|
Assessed by the EuroQol- five dimensions- five level (EQ-5D-5L).
This questionnaire contains 6 items: mobility, self-care, usual activities, pain/discomfort and anxiety/depression and a total score for global health.
The first 5 item have 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems.
The score of these item can range from 0 to 4. The higher the total score of these five items, the lower the quality of live.
The global health scores on a range 0-100.
The higher the score of this item, the higher the global health.
|
M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)
|
Health Related Quality of Life
Time Frame: M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)
|
Assessed by the European organisation for research and treatment for cancer quality of life questionnaire (EORTC QLQ-C30).
This questionnaire contains 30 questions scoring 9 subscales and 6 single items: 5 functional scales, 3 symptom scales and 1 global health / quality of life scale.
The score of each subscale of single items ranges from 0 to 100.
A higher score on the functional scales means a high level of functioning.
A higher score on the symptom scales means a high level of experiencing symptoms.
A higher score on global health / quality of life means a high score of quality of life.
|
M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)
|
Health Related Quality of Life
Time Frame: M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)
|
Assessed by the European organisation for research and treatment for cancer quality of life questionnaire head and neck module (EORTC-QLQ-H&N43).
This questionnaire contains 43 specific head and neck cancer questions scoring 19 subscales of symptoms.
The higher the score of the subscale, the higher the level symptomology.
|
M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)
|
Fatigue
Time Frame: M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)
|
Assessed by the multidimensional fatigue inventory (MFI).
The MFI contains 20 items scoring the following domains: general, physical and mental fatigue, and reduced activity and motivation.
Every scale scores 4 till 20.
The greater the score, the more fatigue or limitations in live because of fatigue.
|
M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)
|
Body composition
Time Frame: M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)
|
body mass index (BMI)
|
M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)
|
Nutrition status
Time Frame: M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)
|
Assessed by the short nutritional assessment questionnaire (SNAQ).
The short nutritional assessment questionnaire (SNAQ) consists of three questions and will be used to monitor nutritional status and assess the risk of malnutrition.
The total score of this questionnaire ranges from 0 to 7. 0 means no nutritional problems and a high score means malnutrition.
|
M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)
|
Physical activity
Time Frame: M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)
|
Assessed by the short questionnaire to assess health enhancing physical activity (SQUASH).
The SQUASH measures the frequency, duration and intensity of 4 different physical activity: physical activity going to work, physical activity during household activity, physical activity at work, physical activity in spare time.
The higher the score, the higher the level of physical activity.
|
M0 (baseline/before (C/B)RT), M1 (12 weeks), M2 (6 months), M3 (12 months)
|
Tolerability of radiotherapy, chemoradiation or bioradiation
Time Frame: M1 (12 weeks), M2 (6 months), M3 (12 months)
|
tolerability will be retrieved from medical records and registered as the percentage of scheduled treatment completion, percentage of (C/B)RT adjustment and type of (C/B)RT adjustment.
|
M1 (12 weeks), M2 (6 months), M3 (12 months)
|
socio-demographic data and medical data
Time Frame: M0 (baseline/before (C/B)RT)
|
age, gender, education, employment, marital status tumour site, disease stage, comorbidity, HPV status, tobacco and alcohol use, nutrition status and type of treatment.
|
M0 (baseline/before (C/B)RT)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Yvette Kriellaars, Msc., Instituut Verbeeten
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NL79549.028.21
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Head and Neck Cancer
-
Robert FerrisAmgenCompletedHead and Neck Cancer | Cancer of Head and Neck | Head Cancer | Neck Cancer | Neoplasms, Head and Neck | Cancer of the Head and Neck | Cancer of Neck | Upper Aerodigestive Tract Neoplasms | Neck Neoplasms | Cancer of the Head | Cancer of the Neck | UADT Neoplasms | Cancer of Head | Head Neoplasms | Head, Neck Neoplasms | Neoplasms, Head and other conditionsUnited States
-
Assiut UniversityRecruitingHead and Neck Cancer | Head and Neck Neoplasms | Cancer of Head and Neck | Neoplasms, Head and Neck | Cancer of the Head and NeckEgypt
-
Mayo ClinicRecruitingCancer Head Neck | Cancer Neck | Cancer, HeadUnited States
-
IRCCS Policlinico S. MatteoNestlé Health Science Spain; Akern SrlCompletedHead-neck CancerItaly
-
University of California, San FranciscoCompleted
-
Chinook Therapeutics, Inc. (formerly Aduro)TerminatedRecurrent Head and Neck Cancer | Metastatic Head and Neck CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedHead And Neck CancerUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Head and Neck Cancer | Metastatic Head and Neck CancerUnited States
-
Radboud University Medical CenterUnknown
-
Centre Oscar LambretUnknownEpidermoid Head and Neck CancerFrance
Clinical Trials on Experimental Intervention
-
Vanderbilt UniversityAgency for Healthcare Research and Quality (AHRQ)Completed
-
Virginia Commonwealth UniversityMind and Life Institute, Hadley, MassachusettsRecruitingEmotion RegulationUnited States
-
Louis BhererMitacs; Université de Montréal; Fonds de la Recherche en Santé du QuébecNot yet recruitingAging | Atrial Fibrillation RecurrentCanada
-
Riphah International UniversityRecruitingEffects of Strength Training on Freestyle Swimming Performance and Core Muscles Strength in SwimmersSports Physical TherapyPakistan
-
Fadoi Foundation, ItalyCompleted
-
The University of Hong KongHaven of Hope Hospital; The Social Innovation and Entrepreneurship Development...Completed
-
Nanjing Medical UniversityNanjing Maternity and Child Health Care Hospital; Jiangsu Maternity and Child... and other collaboratorsRecruitingQuality Improvement | Premature Infant | Breast-feedingChina
-
Goethe UniversityUnknownHealth Knowledge, Attitudes, PracticeGermany
-
Riphah International UniversityCompleted
-
University of OldenburgCompleted